Moreover, another study targeting the PI3K/Akt/mTOR signaling pathway in CF also showed that inhibition of AKT using MK-2206 increased stability and expression of mutant CFTR and that this effect may possibly be mediated by BAG3 [23]. Here, MTOR is linked to cystic fibrosis.